Shares of Galectin Therapeutics Inc. trade on the Nasdaq stock exchange under the ticker symbol GALT, hovering around the $3.68 per share mark. Stock valuations fluctuate continuously throughout active trading sessions based on daily order volumes, broader healthcare sector trends, and periodic corporate announcements regarding its clinical pipeline advancement and capital structure adjustments.